The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat ...

After announcing a $20 million funding round in June, the startup has set its sights on growing its customer-facing workforce ...

Sleep apnea is a condition where breathing repeatedly stops or reduces during sleep, often due to airway obstruction. It ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the ...

Data suggest that OSA diagnoses were associated with an increased risk for physical and psychological problems in active-duty ...

Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...